VanEck Biotech ETF (BBH)
- Expense ratio0.33%
- Net assets$502.0M
- Dividend yield0.40%
- 1-year return+39.42%
- Holdings25
BBH ETF price chart
BBH quote & trading statistics
BBH performance
Annual returns & drawdowns →- YTD+29.53%
- 1 year+39.42%
- 3 years+19.16%/yr
- 5 years+4.97%/yr
- 10 years+9.54%/yr
- 1Y volatility
- 19.81%
- 3Y volatility
- 17.44%
- 3Y Sharpe ratio
- 0.71
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
BBH top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc | 15.55% |
| 2 | GILD | Gilead Sciences Inc | 13.66% |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 8.40% |
| 4 | REGN | Regeneron Pharmaceuticals Inc | 7.02% |
| 5 | MRNA | Moderna Inc | 6.49% |
| 6 | NTRA | Natera Inc | 4.70% |
| 7 | IQV | IQVIA Holdings Inc | 4.54% |
| 8 | ARGX | argenx NV ADR | 4.22% |
| 9 | ILMN | Illumina Inc | 4.08% |
| 10 | RVMD | Revolution Medicines Inc | 3.75% |
The top 10 holdings make up 72.4% of the fund (25 holdings in total). As of October 25, 2026.
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
BBH ETF FAQ
What is the BBH expense ratio?
VanEck Biotech ETF has a net expense ratio of 0.33%, or $33.00 a year for every $10,000 invested.
How much money is in BBH?
VanEck Biotech ETF has about $502.0M in net assets.
What are the top holdings of BBH?
The largest positions in BBH are Amgen Inc (15.55%), Gilead Sciences Inc (13.66%), Vertex Pharmaceuticals Inc (8.40%). The fund holds 25 securities in total.
How has BBH performed?
BBH returned +39.42% over the past year and +4.97% a year over the past five years, including reinvested distributions.
Does BBH pay dividends?
BBH has a dividend yield of 0.40% and pays distributions annual.
When was BBH launched?
VanEck Biotech ETF began trading on December 20, 2011.
ETFs similar to BBH
Funds that track the same index or whose top-10 holdings overlap most with BBH's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.